West Pharmaceutical Services, Inc. ( WST) - Key Metrics
WST Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q1 | ? | ? | ? | ? |
| 2025Q4 | $11.13 | $1.83 | $3.47 | $2.42 |
| 2025Q3 | $11.12 | $1.94 | $2.73 | $1.85 |
| 2025Q2 | $10.60 | $1.82 | $2.45 | $1.41 |
| 2025Q1 | $9.63 | $1.24 | $1.78 | $0.80 |
WST Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q1 | ? | ? |
| 2025Q4 | 11.96% | 37.65 |
| 2025Q3 | 10.79% | 33.87 |
| 2025Q2 | 11.46% | 30.01 |
| 2025Q1 | 16.93% | 45.19 |
WST Free Cash Flow Yield and Dividend Yield
| Date | Free Cash Flow Yield | Dividend Yield |
|---|---|---|
| 2026Q1 | 0.26% | ? |
| 2025Q4 | 0.88% | 0.08% |
| 2025Q3 | 0.71% | 0.08% |
| 2025Q2 | 0.64% | 0.10% |
| 2025Q1 | 0.36% | 0.09% |
WST
List: Champions
Price: $358.72
Dividend Yield: 0.24%
Forward Dividend Yield: 0.25%
Payout Ratio: 11.36%
Dividend Per Share: 0.88 USD
Earnings Per Share: 7.47 USD
P/E Ratio: 39.54
Exchange: NYQ
Sector: Healthcare
Industry: Medical Instruments & Supplies
Country: United States
Volume: 800100
Ebitda: 85.9 millionMarket Capitalization: 25.8 billion
Average Dividend Frequency: 4
Years Paying Dividends: 42
DGR3: 5.34%
DGR5: 5.67%
DGR10: 6.81%
DGR20: 6.93%